{"id":"https://openalex.org/W2158558263","doi":"https://doi.org/10.1016/j.jval.2015.05.007","title":"Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom","display_name":"Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom","publication_year":2015,"publication_date":"2015-07-27","ids":{"openalex":"https://openalex.org/W2158558263","doi":"https://doi.org/10.1016/j.jval.2015.05.007","mag":"2158558263","pmid":"https://pubmed.ncbi.nlm.nih.gov/26409607"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2015.05.007","doi":"https://doi.org/10.1016/j.jval.2015.05.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.05.007","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jval.2015.05.007","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001794200","display_name":"Sarah L. Bermingham","orcid":"https://orcid.org/0009-0002-0447-7079","observed_orcids":["https://orcid.org/0009-0002-0447-7079"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sarah L. Bermingham","raw_affiliation_strings":["Symmetron Limited, Toronto, Ontario, Canada. Electronic address: s.l.bermingham@gmail.com","Symmetron Limited, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Symmetron Limited, Toronto, Ontario, Canada. Electronic address: s.l.bermingham@gmail.com","institution_ids":[]},{"raw_affiliation_string":"Symmetron Limited, Toronto, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ralph Hughes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4339842","display_name":"Royal College of Physicians","ror":"https://ror.org/0530xmm89","country_code":"GB","type":"education","lineage":["https://openalex.org/I4339842"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ralph Hughes","raw_affiliation_strings":["Royal College of Physicians, National Clinical Guideline Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal College of Physicians, National Clinical Guideline Centre, London, UK","institution_ids":["https://openalex.org/I4339842"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085700120","display_name":"Elisabetta Fenu","orcid":"https://orcid.org/0000-0001-7666-3319","observed_orcids":["https://orcid.org/0000-0001-7666-3319"]},"institutions":[{"id":"https://openalex.org/I4339842","display_name":"Royal College of Physicians","ror":"https://ror.org/0530xmm89","country_code":"GB","type":"education","lineage":["https://openalex.org/I4339842"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elisabetta Fenu","raw_affiliation_strings":["Royal College of Physicians, National Clinical Guideline Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal College of Physicians, National Clinical Guideline Centre, London, UK","institution_ids":["https://openalex.org/I4339842"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045033407","display_name":"L. Sawyer","orcid":"https://orcid.org/0000-0002-0854-6222","observed_orcids":["https://orcid.org/0000-0002-0854-6222"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura M. Sawyer","raw_affiliation_strings":["Symmetron Limited, Borehamwood, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Symmetron Limited, Borehamwood, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090705887","display_name":"Elizabeth H. Boxall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104666","display_name":"Heartlands Hospital","ror":"https://ror.org/01bd5gh54","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210104666"]},{"id":"https://openalex.org/I4387154524","display_name":"Health Protection Agency","ror":"https://ror.org/022pm7h15","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I1311074006","https://openalex.org/I348769827","https://openalex.org/I4387154524"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Boxall","raw_affiliation_strings":["Virology Laboratory, Health Protection Agency, Microbiology Services Division, Heartlands Hospital, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology Laboratory, Health Protection Agency, Microbiology Services Division, Heartlands Hospital, Birmingham, UK","institution_ids":["https://openalex.org/I4210104666","https://openalex.org/I4387154524"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015295914","display_name":"Patrick T.F. Kennedy","orcid":"https://orcid.org/0000-0001-9201-0094","observed_orcids":["https://orcid.org/0000-0001-9201-0094"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Patrick T. Kennedy","raw_affiliation_strings":["Barts and The London School of Medicine and Dentistry, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts and The London School of Medicine and Dentistry, London, UK","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052742729","display_name":"Geoffrey M Dusheiko","orcid":"https://orcid.org/0000-0002-9579-4469","observed_orcids":["https://orcid.org/0000-0002-9579-4469","https://orcid.org/0000-0001-5214-5824"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Geoff Dusheiko","raw_affiliation_strings":["UCL Institute of Liver and Digestive Health, Royal Free Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCL Institute of Liver and Digestive Health, Royal Free Hospital, London, UK","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048001382","display_name":"Grant A. Hill-Cawthorne","orcid":"https://orcid.org/0000-0002-3828-5473","observed_orcids":["https://orcid.org/0000-0002-3828-5473"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Grant Hill-Cawthorne","raw_affiliation_strings":["Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney School of Public Health, University of Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney School of Public Health, University of Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111964233","display_name":"Howard C. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Howard Thomas","raw_affiliation_strings":["Section of Hepatology and Gastroenterology, Department of Medicine, Imperial College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hepatology and Gastroenterology, Department of Medicine, Imperial College, London, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5001794200"],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":2.8009,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.89433512,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"18","issue":"6","first_page":"800","last_page":"809"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.09709999710321426,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.843999981880188},{"id":"https://openalex.org/keywords/antiviral-treatment-strategies","display_name":"antiviral treatment strategies","score":0.824999988079071},{"id":"https://openalex.org/keywords/hbeag-positive-chronic-hepatitis-b","display_name":"HBeAg-positive hepatitis B","score":0.8999999761581421},{"id":"https://openalex.org/keywords/hbeag-negative-chronic-hepatitis-b","display_name":"HBeAg-negative hepatitis B","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pegylated-interferon-alpha-2a","display_name":"pegylated interferon alpha-2a","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.996999979019165},{"id":"https://openalex.org/keywords/entecavir","display_name":"entecavir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nucleos-t-ide-analogues","display_name":"nucleos(t)ide analogues","score":0.8299999833106995},{"id":"https://openalex.org/keywords/hbeag-seroconversion","display_name":"HBeAg seroconversion","score":0.9169999957084656},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.6880000233650208},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.550000011920929},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.45100000500679016},{"id":"https://openalex.org/keywords/united-kingdom","display_name":"United Kingdom","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8596997261047363},{"id":"https://openalex.org/C2776175608","wikidata":"https://www.wikidata.org/wiki/Q418586","display_name":"Entecavir","level":5,"score":0.8595614433288574},{"id":"https://openalex.org/C2775940106","wikidata":"https://www.wikidata.org/wiki/Q10478733","display_name":"HBeAg","level":5,"score":0.7681652307510376},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.5748507380485535},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5069646835327148},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.4446672201156616},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.4386264383792877},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.42218494415283203},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3685634732246399},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1910390853881836},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.18106019496917725},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.15989801287651062},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.06369039416313171}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003661","descriptor_name":"Decision Support Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006513","descriptor_name":"Hepatitis B e Antigens","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013222","descriptor_name":"State Medicine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057186","descriptor_name":"Comparative Effectiveness Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jval.2015.05.007","doi":"https://doi.org/10.1016/j.jval.2015.05.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.05.007","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},{"id":"pmid:26409607","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26409607","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research","raw_type":"Comparative Study"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1494447","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1494447/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"VALUE IN HEALTH , 18 (6) pp. 800-809. (2015)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2015.05.007","doi":"https://doi.org/10.1016/j.jval.2015.05.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2015.05.007","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W1526839166","https://openalex.org/W1945941162","https://openalex.org/W1967751247","https://openalex.org/W1971303441","https://openalex.org/W1973201198","https://openalex.org/W1976104517","https://openalex.org/W1982812988","https://openalex.org/W1987409559","https://openalex.org/W1991094067","https://openalex.org/W1999664635","https://openalex.org/W2008517556","https://openalex.org/W2009509017","https://openalex.org/W2009663598","https://openalex.org/W2012090731","https://openalex.org/W2014837723","https://openalex.org/W2017172077","https://openalex.org/W2017537010","https://openalex.org/W2018479084","https://openalex.org/W2022625249","https://openalex.org/W2022770725","https://openalex.org/W2024593231","https://openalex.org/W2025530770","https://openalex.org/W2028098661","https://openalex.org/W2028622775","https://openalex.org/W2040434234","https://openalex.org/W2048759891","https://openalex.org/W2048841284","https://openalex.org/W2055002900","https://openalex.org/W2059560167","https://openalex.org/W2073029663","https://openalex.org/W2073466847","https://openalex.org/W2080705326","https://openalex.org/W2084720260","https://openalex.org/W2089571778","https://openalex.org/W2089727509","https://openalex.org/W2098472552","https://openalex.org/W2104780490","https://openalex.org/W2108147025","https://openalex.org/W2115123213","https://openalex.org/W2122087900","https://openalex.org/W2133291642","https://openalex.org/W2137544368","https://openalex.org/W2142557452","https://openalex.org/W2152532978","https://openalex.org/W2156015715","https://openalex.org/W2158820949","https://openalex.org/W2160654288","https://openalex.org/W2162968224","https://openalex.org/W2415371986","https://openalex.org/W2739535516","https://openalex.org/W3030265267","https://openalex.org/W3135185800","https://openalex.org/W3138395598","https://openalex.org/W3149727786","https://openalex.org/W4241710806","https://openalex.org/W6792068238"],"related_works":["https://openalex.org/W2409227219","https://openalex.org/W2098472552","https://openalex.org/W7152685243","https://openalex.org/W2119010872","https://openalex.org/W2048001245","https://openalex.org/W4241277544","https://openalex.org/W3176912797","https://openalex.org/W2185350149","https://openalex.org/W1971303441","https://openalex.org/W2974466373"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}